MARKET

CTKB

CTKB

Cytek Biosciences, Inc.
NASDAQ
2.925
-0.865
-22.82%
After Hours: 2.970 +0.045 +1.54% 19:58 05/09 EDT
OPEN
3.100
PREV CLOSE
3.790
HIGH
3.470
LOW
2.865
VOLUME
2.22M
TURNOVER
--
52 WEEK HIGH
7.63
52 WEEK LOW
2.865
MARKET CAP
373.23M
P/E (TTM)
-63.4490
1D
5D
1M
3M
1Y
5Y
1D
Cytek Biosciences: Earnings Call Reveals Mixed Fortunes
TipRanks · 19h ago
Piper Sandler Sticks to Its Buy Rating for Cytek Biosciences (CTKB)
TipRanks · 1d ago
CYTEK BIOSCIENCES INC <CTKB.O>: TD COWEN CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $4 FROM $7
Reuters · 1d ago
Cytek Biosciences downgraded to Hold from Buy at TD Cowen
TipRanks · 1d ago
Cytek Biosciences Faces Revenue Challenges and Market Uncertainty, Downgraded to Hold
TipRanks · 1d ago
U.S. RESEARCH ROUNDUP-Certara, Curtiss-Wright, McKesson
Reuters · 1d ago
Cytek Biosciences Reports Q1 2025 Financial Results
TipRanks · 1d ago
Cytek Biosciences GAAP EPS of -$0.09 misses by $0.04, revenue of $41.5M misses by $1.16M
Seeking Alpha · 1d ago
More
About CTKB
More
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content, and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Its platform includes its core FSP instruments, the Cytek Aurora and Northern Lights systems and the Cytek Aurora CS cell sorter; the Cytek Orion reagent cocktail preparation system; the Enhanced Small Particle (ESP) detection technology; the flow cytometer and imaging products under the Amnis and Guava brands, and reagents, software and service to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Northern Lights systems are used in the study of infectious diseases, immunology, immunotherapy, immuno-oncology, oncology, and drug discovery. The Cytek Orion reagent cocktail preparation system enables researchers to fully automate the preparation of antibody cocktails for flow cytometry.
Recently
Symbol
Price
%Change

Webull offers Cytek Biosciences Inc stock information, including NASDAQ: CTKB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTKB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTKB stock methods without spending real money on the virtual paper trading platform.